https://www.thebodypro.com/author/sony-salzman

Latest by Sony Salzman

Promo Image
News

What Is the State of the Art in HIV Treatment and Prevention?

With several new regimens nearing late-stage trials, a new generation of HIV antiretrovirals may soon be entering the marketplace.

Man holdin his head
Neurocognitive

Lessons for Infectious Disease Doctors: Treating HIV, Pain, and Mental Illness

A staggering 60% of patients with HIV experience chronic pain compared with only 11% of the general population, according to Robert Bruce, M.D., M.A., M.Sc., who presented the latest research on pain and HIV at IDWeek 2018.

Allison Glaser, M.D.
News

New York City's Hotline for HIV Exposure a Success, Study Finds

A dial-in hotline program in New York City has helped qualified patients access post-exposure prophylaxis (PEP) at their local pharmacies, raising the possibility that remote screening methods could be an important way to bolster PEP use.

Anisha Apte, B.S.
Cancer

New Study From Georgia Sheds Light on Kaposi Sarcoma in Women With HIV

The skin cancer Kaposi Sarcoma (KS) is an HIV-related condition that primarily affects men, but a new cases series presented at IDWeek 2018 in San Francisco highlights the importance of studying women with KS.

Jodian Pinkney, M.D.
Jamaica

Jamaican Study of Serodiscordant Couples Highlights Challenges of PrEP Awareness

A poster presented at the annual IDWeek conference in San Francisco illustrated the lag between the World Health Organization's recommendations and PrEP uptake in an urban setting in Jamaica.

Eric Daar, M.D., and Claudia S. Crowell, M.D., M.P.H.
Children (Ages 0-17)

Neurological Conditions More Likely Among Children Exposed to Efavirenz in Utero

Efavirenz (Sustiva, Stocrin) use was associated with a 60% increased risk of neurological conditions in children, according to data presented at IDWeek 2018 in San Francisco.

Melanie Thompson, M.D.
News

What's Hot in HIV Clinical Science

Melanie Thompson, M.D., provided a round up of this year's successes failures in HIV clinical research at IDWeek 2018 in San Francisco.

The DMV Balenciaga House Meeting
Hepatitis C

With Only 15% of Diagnosed HCV Patients Receiving Treatment, the Non-Profit I-MAK Hopes to Shift the National Conversation on Drug Pricing

The Initiative for Medicines, Access and Knowledge, Inc. (I-MAK) argues that the high price of hepatitis C cure medicines places them out of reach for most people.

Research Is Still Exploring Best Treatment Strategies for Pregnant and Breastfeeding Women, Interactions With Contraceptives Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Research Is Still Exploring Best Treatment Strategies for Pregnant and Breastfeeding Women, Interactions With Contraceptives

Several new studies presented at the annual Conference on Retroviruses and Opportunistic Infections (CROI) underscore the complex ways that HIV risk and treatment adherence manifest among women of childbearing age.

HIV/HCV Coinfection: New Data Has Implications for Treatment-as-Prevention Efforts Img
Hepatitis C

HIV/HCV Coinfection: New Data Has Implications for Treatment-as-Prevention Efforts

Researchers at this year's Conference on Retroviruses and Opportunistic Infections (CROI) presented their findings on the ongoing challenges of treating hepatitis C infection among people with HIV.